Related topics: Commercial Services, Contract sales & marketing
Commercial services firm PDI says the renewal of contract sales agreement between its SAT unit and a “major” pharmaceutical firm will generate some $6.6m (€5.1m) this year.
PDI’s Select Access Team (SAT), part of its “on demand” sales service, will continue to target paediatrician in the US. The firm was unwilling to provide further details of the products being marketed or the pharmaceutical client involved.
CEO Nancy Lurker said renewal of the contract was “a strong vote of confidence for PDI’s sales execution and the flexibility and return on investment we are able to offer our pharmaceutical company customers.”
Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions